🔎 Trials Near Me

홈 › 폐암 › 캘리포니아

캘리포니아의 폐암 임상 시험

폐암 관련 연구 114개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Sansum Clinic, Santa Barbara
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  • Local Institution - 0497, Los Alamitos
  • USC/Norris Comprehensive Cancer Center, Los Angeles
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07063745

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building, Irvine
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Providence Medical Foundation, Fullerton
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
  • Providence St. Jude Medical Center, Fullerton
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Tower Cancer Research Foundation, Beverly Hills
  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • 외 20개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06498635

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  • OPN Healthcare, Glendale
  • MemorialCare Todd Cancer Institute, Long Beach
  • Valkyrie Clinical Trials, Los Angeles
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07625644

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Kaiser Permanente-Anaheim, Anaheim
  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Sutter Auburn Faith Hospital, Auburn
  • 외 56개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

  • VA Palo Alto Health Care System, Palo Alto
피험자 모집 중
50세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07168993

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • UCSF Cancer Center Burlingame, Burlingame
  • Veterans Affairs Loma Linda Healthcare System, Loma Linda
피험자 모집 중3상
70세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06096844

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Cedars-Sinai Medical Center, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07458347

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Cedars-Sinai Medical Center, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Beverly Hills Cancer Center ( Site 0070), Beverly Hills
  • UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
  • Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06312137

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

  • GSK Investigational Site, Los Angeles
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07099898

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

  • City of Hope Medical Center, Duarte
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07664579

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • UC Irvine Health, Orange
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06881784

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
  • Naval Medical Center -San Diego, San Diego
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Oncura Health, Glendale
  • UC San Diego Health - Moores Cancer Center, La Jolla
  • California Research Institute, Los Angeles
  • 외 4개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
피험자 모집 중초기 1상
22세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07235280

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • Community Cancer Institute (CCI), Clovis
  • Marin Cancer Care Inc, Greenbrae
  • UCI Health-CIACC, Irvine
  • 외 6개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06793215

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05366881

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • 외 22개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • UCSF Cancer Center Burlingame, Burlingame
  • Kaiser Permanente Dublin, Dublin
  • 외 24개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Providence Medical Foundation (site 209), Santa Rosa
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT03556228

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0096, San Francisco
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07492680

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • 외 10개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Cedars-Sinai Medical Center, Los Angeles
  • BASS Cancer Center, Walnut Creek
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

  • The Angeles Clinic and Research Institute (Melanoma), Los Angeles
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
  • Stanford Cancer Institute (Melanoma/NSCLC), Stanford
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06060613

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • John Muir Clinical Research Center, Concord
  • University Of California - San Diego Moores Cancer Center, La Jolla
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06712316

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • St. Jude Medical Center, Fullerton
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Providence St. Joseph Hospital, Orange
  • 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07185997

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  • City of Hope National Medical Center, Duarte
  • Hoag Memorial Hospital Presbyterian, Newport Beach
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07499674

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • UC San Diego Moores Cancer Center, La Jolla
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06287775

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

  • City of Hope Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06014827

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • OPN Healthcare, Inc., Glendale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05168566

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • VA Long Beach Healthcare System, Long Beach, CA, Long Beach
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT02984761

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07154290

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Los Angeles
피험자 모집 중2상
18세 ~ 95세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05061550

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of California, Irvine, Irvine
  • University of California Los Angeles, Los Angeles
  • University of California at San Francisco, San Francisco
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06810544

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06582017

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.